Shares of Sartorius (OTCPK:SARTF) spiked in European trading on Wednesday after the German life sciences company recorded a strong start to 2025, with its Q1 results sending its U.S. peers higher ...

Sales revenue at 745 million euros, up 10.4 percent in constant currencies 1 (reported: 11.7 percent) Sartorius Stedim Biotech, a leading partner to the biopharmaceutical industry, started the fiscal ...

Guidance for 2025 EBITDA Margin: Expected between 29% to 30%. Sartorius Stedim Biotech SA (SDMHF) reported a strong start to 2025 with a 10% increase in sales revenue for Bioprocess Solutions ...

Tom is a writer in London with a Master's degree in Journalism whose editorial work covers anything from health and the environment to technology and archaeology. Scientists have created nugget ...

Investing.com -- Sartorius (F:SATG) has been upgraded to “buy” from “hold” by Deutsche Bank, with analyst Falko Friedrichs lowering the price target to €270 from €285. The upgrade ...

Sartorius Stedim Biotech SA (DIM), with a market capitalization of $135.93 million, reported robust earnings for the first quarter of 2025, exceeding analyst expectations with an earnings per ...

2025 Group EBITDA Margin Guidance: 29% to 30%. 2025 CapEx Ratio Guidance: Around 12.5%. Sartorius AG (SARTF) reported a strong start to 2025 with a 6.5% sales revenue growth in constant currencies.

At its certified sites, Sartorius produces Ambr ® bioreactor vessels, Vivaflow ® filters, and selected Flexsafe ® bags for the manufacture of biopharmaceuticals. ISCC’s transparent accounting ...

People with sartorius muscle pain may have pain in their knee or the front of their hip. Certain exercises can help strengthen the muscle and reduce pain. The sartorius is the longest muscle in a ...

The BioXplorer 100 from H.E.L is a multi-bioreactor system that has been specifically developed for the optimization of aerobic fermentations. Having a working volume as low as 50 mL, the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...